YD Bio YDES
NASDAQ YDES
$2.63 +0.00 (+0.19%)
As of: Sep 22, 2026 · 11:58 AM EDT

YD Bio (YDES) Share-based Compensation (2026)

YD Bio's (YDES) quarterly Share-based Compensation came in at $30000.0 in Q2 2026.

Analysis

YD Bio (YDES) Share-based Compensation (2026) Analysis & Trends

YD Bio (YDES) has reported Share-based Compensation for 1 consecutive years, with $30000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Share-based Compensation changed N/A year-over-year to $30000.0 in Q2 2026; TTM through Jun 2026 was $30000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $20471.0, up 74.5% from the prior year.
  • Share-based Compensation was $30000.0 for Q2 2026 at YD Bio.
  • Over five years, Share-based Compensation peaked at $30000.0 in Q2 2026 and troughed at $30000.0 in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 243.00 Mn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 120.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 86.63 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 77.40 Mn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 83.34 Mn
10 YD Bio 225.82 Mn 223.16 Mn - 30,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30,000.00
API Access

YD Bio Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=YDES&period=max&api_key=YOUR_API_KEY